Advanced Search

Technical Analysis for VXRT - Vaxart, Inc.

Grade Last Price % Change Price Change
grade B 7.98 -2.56% -0.21
VXRT closed down 2.56 percent on Friday, July 10, 2020, on 55 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
56 Watchers
Watchlist Portfolio

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical VXRT trend table...
Date Alert Name Type % Chg
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Boomer Buy Setup Bullish Swing Setup -2.56%
Narrow Range Bar Range Contraction -2.56%
NR7 Range Contraction -2.56%
NR7-2 Range Contraction -2.56%
Older EOD signals for VXRT ...
View Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators Basic chart:

Profile

Vaxart, Inc., a clinical-stage company, focuses on developing oral recombinant vaccines based on its proprietary oral vaccine delivery platform. The company's platform delivers various recombinant protein antigens, such as those used in influenza, hepatitis B, and human papilloma virus (HPV) vaccines, as well as other recombinant vaccines. Its development programs include oral tablet vaccines that are designed to protect against norovirus, seasonal influenza, and respiratory syncytial virus, as well as a therapeutic vaccine for HPV. The company is headquartered in South San Francisco, California.
Medicine Cancer Medical Specialties Coronavirus Influenza Vaccination Infectious Causes Of Cancer Vaccine Hepatitis B Human Papillomavirus Infection Seasonal Influenza HPV Human Papilloma Virus Papillomavirus

Is VXRT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Jul 11 Everything You Need to Know About Vaxart and Its Potential Coronavirus Vaccine
Jul 9 Mixed shelf roundup - healthcare
Jul 9 Coronavirus Vaccine Race: Moderna or Vaxart?
Jul 9 Is Vaxart Stock a Buy?
Jul 8 Moderna completes enrollment in mid-stage study of COVID-19 vaccine
Jul 8 Better Coronavirus Stock: Altimmune vs. Vaxart
Jul 7 Better Coronavirus Stock: VBI Vaccines or Vaxart?
Jul 6 Vaxart's Technology Could Be A COVID-19 Game Changer
Jul 6 Vaxart: A Speculative Buy For Its Oral COVID-19 Vaccine
Jul 6 Emergent BioSolutions inks coronavirus vaccine manufacturing deal with J&J
See more VXRT news...

Indicators

Indicator Value
52 Week High 14.3
52 Week Low 0.2543
Average Volume 18,570,979
200-Day Moving Average 1.69
50-Day Moving Average 3.81
20-Day Moving Average 5.45
10-Day Moving Average 7.94
Average True Range 1.23
ADX 40.93
+DI 44.18
-DI 15.76
Chandelier Exit (Long, 3 ATRs ) 10.62
Chandelier Exit (Short, 3 ATRs ) 5.93
Upper Bollinger Band 10.76
Lower Bollinger Band 0.13
Percent B (%b) 0.74
BandWidth 195.16
MACD Line 1.46
MACD Signal Line 1.24
MACD Histogram 0.2268
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.79
Resistance 3 (R3) 8.76 8.45 8.66
Resistance 2 (R2) 8.45 8.25 8.47 8.61
Resistance 1 (R1) 8.22 8.12 8.07 8.25 8.56
Pivot Point 7.91 7.91 7.84 7.93 7.91
Support 1 (S1) 7.68 7.71 7.53 7.71 7.40
Support 2 (S2) 7.37 7.58 7.39 7.35
Support 3 (S3) 7.14 7.37 7.31
Support 4 (S4) 7.17